Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

Clinical trial NCT07549451 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07549451
Sponsor: M.D. Anderson Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Phase II Imetelstat Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases

Start date: 2026-10-08
Primary completion: 2027-05-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.